EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential

Monika Marcinkowska iD, Joanna Sniecikowska iD, Monika Głuch-Lutwin, Barbara Mordyl, Marek Bednarski, Adam Bucki iD, Michał Sapa, Monika Kubacka iD, Agata Siwek, Agnieszka Zagórska iD, Jacek Sapa, Marcin Kołaczkowski und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Monika Marcinkowska und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Metabolic Diseases, Guanidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jagiellonian University, Priority Research Area qLIFE under the Strategic Programme Excellence Initiative, Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TAAR1 agonists have emerged as promising therapeutic agents capable of modulating glucose homeostasis, enhancing insulin secretion and suppressing appetite, making them attractive candidates for the treatment of obesity and related metabolic disorders. Despite their potential, the number of TAAR1-targeting compounds with well-defined pharmacological profiles remains limited. In this study, we identified and characterized JP-14, a novel aminoguanidine-based TAAR1 agonist, in a comprehensive panel of pharmacological assays. JP-14 promoted glucose uptake in HepG2 cells and reduced lipid deposition during 3T3-L1 adipocyte differentiation, with both actions dependent on TAAR1 signaling. In differentiated 3T3-L1 adipocytes, JP-14 reduced intracellular levels of both neutral lipids and phospholipids, indicating dual anti-steatotic and anti-phospholipidotic activity. In zebrafish larvae, toxicity profiling confirmed 10 µg/mL as a safe concentration for further in vivo studies. These assays showed that JP-14 promoted lipid mobilization and partially prevented fructose-induced lipid accumulation, demonstrating systemic metabolic benefits in vivo. Moreover, JP-14 markedly delayed gastric emptying in mice, an effect similar to loperamide and reversed by TAAR1 antagonism, supporting its role in regulating satiety and energy balance. Collectively, our findings establish JP-14 as a safe and metabolically active TAAR1 agonist with multifaceted effects on glucose and lipid metabolism. JP-14 represents a valuable pharmacological tool for probing TAAR1-mediated mechanisms in metabolic regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledMetabolic DiseasesGuanidinesAnimalsMiceHumansZebrafishLipid MetabolismHep G2 CellsGlucose3T3-L1 CellsAdipocytesCell DifferentiationMice, Inbred C57BLMaleTrace Amine-Associated Receptors

Stichwörter der Autor:innen

TAAR1aminoguanidine-based ligandgastric emptyinglipid metabolismtrace amine-associated receptor 1 agonist

Substanzen

Receptors, G-Protein-CoupledGlucoseGuanidinesTrace Amine-Associated Receptors

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland.
  • Department of Pharmacobiology, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland.
  • Laboratory of Pharmacological Screening, Department of Pharmacodynamics, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland.

ORCID-Profile: Monika Marcinkowska, Joanna Sniecikowska, Adam Bucki, Monika Kubacka, Agnieszka Zagórska, Magdalena Kotańska

Förderung

  • Jagiellonian University, Priority Research Area qLIFE under the Strategic Programme Excellence Initiative
  • Priority Research Area qLIFE under the Strategic Programme Excellence Initiative at Jagiellonian University

Zitieren

APA

Marcinkowska, M., Sniecikowska, J., Głuch-Lutwin, M., Mordyl, B., Bednarski, M., Bucki, A., Sapa, M., Kubacka, M., Siwek, A., Zagórska, A., Sapa, J., Kołaczkowski, M., & Kotańska, M. (2025). JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010033

Vancouver

Marcinkowska M, Sniecikowska J, Głuch-Lutwin M, Mordyl B, Bednarski M, Bucki A, et al. JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010033

BibTeX
@article{Marcinkowska2025,
  author = {Marcinkowska, Monika and Sniecikowska, Joanna and Głuch-Lutwin, Monika and Mordyl, Barbara and Bednarski, Marek and Bucki, Adam and Sapa, Michał and Kubacka, Monika and Siwek, Agata and Zagórska, Agnieszka and Sapa, Jacek and Kołaczkowski, Marcin and Kotańska, Magdalena},
  title = {JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010033}
}
Kostenlos starten →